Support: +1 (203) 804-1318

KD-Validated CBX8 Mouse mAb (20 μl)

$149.00

Cat. #: 63809

Description

Reactivity: Human
Applications: WB, FC
Host Species: Mouse
Isotype: IgG2b
Clonality: Monoclonal antibody
Gene Name: chromobox 8
Gene Symbol: CBX8
Synonyms: PC3; RC1
Gene ID: 57332
UniProt ID: Q9HC52
Clone ID: 24GB7980
Immunogen: Recombinant protein of human CBX8
Dilution: WB 1:200-1:1,000; FC 1:1,000
Purification Method: Affinity purified
Concentration: Lot dependent
Buffer: PBS with 0.01% thimerosal, 50% glycerol, pH7.3.
Storage: Store at -20°C. Avoid freeze/thaw cycles.


Background

Enables methylated histone binding activity. Involved in negative regulation of transcription by RNA polymerase II. Located in chromatin and nucleoplasm. Part of PRC1 complex. Biomarker of esophagus squamous cell carcinoma and glioblastoma.


Images

CBX8 antibody Western blotting analysis using anti-chromobox 8 antibody (Cat#63809). Total cell lysates (30 μg) from various cell lines were loaded and separated by SDS-PAGE. The blot was incubated with anti-chromobox 8 antibody (Cat#63809, 1:1,000) and HRP-conjugated goat anti-mouse secondary antibody (Cat#101, 1:20,000) respectively. Image was developed using FeQ™ ECL Substrate Kit (Cat#226).
63809 WB KD 1 Western blotting analysis using anti-chromobox 8 antibody (Cat#63809). Chromobox 8 expression in wild-type (WT) and chromobox 8 (CBX8) shRNA knockdown (KD) HeLa cells with 20 μg of total cell lysates. Hsp90 α serves as a loading control. The blot was incubated with anti-chromobox 8 antibody (Cat#63809, 1:1,000) and HRP-conjugated goat anti-mouse secondary antibody (Cat#101, 1:20,000) respectively. Image was developed using NaQ™ ECL Substrate Kit (Cat#716).
63809 FCM 1 Flow cytometric analysis of Chromobox 8 expression in HeLa cells using anti-Chromobox 8 antibody (Cat#63809, 1:1,000). Green, isotype control; red, Chromobox 8.


You may also be interested in:

Reviews

There are no reviews yet.

Be the first to review “KD-Validated CBX8 Mouse mAb (20 μl)”

Your email address will not be published. Required fields are marked *